What Does Not Affect Surgical Outcomes in NSCLC? What Does Not Affect Surgical Outcomes in NSCLC?

AEGEAN is one of the first studies of immune checkpoint inhibitors in the perioperative settings to demonstrate improved EFS and pCR with no effect on surgical outcomes.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news